Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARTHENOPE: Cre8 vs Synergy Stents and Personalized vs Standard DAPT
NCT04135989Phase 4Active, not recruiting
- Sponsor
- University of Naples Federico II
- Start
- Jan 2020
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel, prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by University of Naples Federico II. Started Jan 2020; status: active, not recruiting.
02
Drugs
aspirinclopidogrelprasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04135989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135989.